CCL17 is a homeostatic chemokine associated with several human inflammatory pathologies. This makes CCL17 a potential point of intervention in inflammatory diseases. Using a Fab-pIX phage display system we were able to select antibodies that specifically bind to CCL17 and neutralize CCL17-mediated signaling. Many of the selected antibodies belong to the V H 1-69 germline gene family. The V H 1-69 germline gene is represented at a high frequency in the human antibody repertoire and is seen in the early immune response to a variety of pathogens. The heavy chain CDR2 of this germline gene is notably hydrophobic and can insert into hydrophobic pockets of antigens, providing much of the binding energy for these antibodies. Affinity maturation of our primary binders by light chain mutagenesis produced antibodies with sub-nanomolar affinities, with affinity improvements up to 100-fold. These were screened for non-specific protein -protein interactions as a filter for solubility. All of our high affinity antibodies were found to have high levels of non-specific protein -protein interactions. We speculated that this was due to the hydrophobicity within the germline heavy chain CDR1 and CDR2. To ameliorate this problem, we generated a phage display library for one of the clones, where the surface-exposed residues within H-CDR1 and H-CDR2 were randomized. High stringency panning of this library against human CCL17 resulted in further affinity improvement, along with reduction in protein-protein interaction in some new variants. In addition, we improved the cross-reactivity to cynomolgus CCL17. We demonstrate that affinity maturation through targeted libraries in the V H 1-69 germline gene can improve both affinity and biophysical characteristics of antibodies derived from this gene scaffold.
Introduction CCL17 (TARC) is an 8-kDa homeostatic chemokine which binds and signals through the chemokine receptor CCR4 (Imai et al., 1997) . Several human diseases including ulcerative colitis, atopic dermatitis, idiopathic pulmonary fibrosis and asthma have been associated with overexpression of this chemokine (Kakinuma et al., 2001; Belperio et al., 2004; Inoue et al., 2004; Saeki and Tamaki, 2006; Tamaki et al., 2006; Christophi et al., 2012) . CCL22 (MDC) is the only other chemokine demonstrated to function through CCR4 (Imai et al., 1996) . Though CCL17 and CCL22 have different expression profiles in vivo, some cell types produce both and the two ligands compete for CCR4 binding, confounding understanding of the contribution of each to establishing inflammatory sites (Imai et al., 1998; Berin et al., 2001; Alferink et al., 2003) . Neutralizing CCL17 could help ameliorate the inflammatory response seen in the aforementioned diseases. Monoclonal antibodies are a well-established means to diminish the effects of inflammatory cytokines and chemokines, therefore we engaged in a screen for anti-CCL17 antibodies.
We utilized a de novo Fab phage display library (Shi et al., 2010) for isolation of antibodies specific to CCL17. This library is comprised of three heavy chain germline genes (V H 1-69, V H 3-23 and V H 5-51) with diversity in H-CDR3 and low diversity in H-CDR1 and H-CDR2, paired with four kappa light chain genes (V k 1-39, V k 3-11, V k 3-20 and V k 4-1) in germline or synthetically diversified formats. Isolated antibodies were affinity matured by generating and panning light chain libraries, and matured clones were analyzed for affinity and activity. All of the affinity matured antibodies demonstrated neutralization of CCL17-mediated signaling through CCR4. Many of the antibodies to CCL17 were from the V H 1-69 germline gene, which is notable for its hydrophobic H-CDR2 (Lerner, 2011; Lingwood et al., 2012; Xu et al., 2013) .
Solubility of antibodies is a key property for development as therapeutic molecules and is influenced by self-association. The propensity for self-association can be empirically measured through cross-interaction chromatography (Jacobs et al., 2010) , but the nature of protein-protein interactions is often difficult to delineate. Hydrophobic interactions were shown to be critical components of protein folding and protein-protein binding (Dill, 1990; Jones and Thornton, 1996) . Several groups have demonstrated the effects of hydrophobic interactions on protein solubility and protein-protein interactions (Jespers et al., 2004b; Conrath et al., 2005; Chennamsetty et al., 2009; Pepinsky et al., 2010; . The re-orientation of a single hydrophobic residue of a V HH domain antibody proved to be sufficient to improve solubility and monomeric state of the molecule (Jespers et al., 2004b) . Phage display techniques to select for aggregationresistant antibodies were subsequently developed (Jespers et al., 2004a) and use of such techniques has resulted in the isolation of antibodies with reduced overall hydrophobicity (Dudgeon et al., 2009) . More recently, computational modeling was developed to examine surface hydrophobicity as an indicator of potential aggregation (Chennamsetty et al., 2010; Chaudhri et al., 2012) . Although hydrophobic interactions are considered to contribute, other factors that enhance aggregation have been identified as well (Shire et al., 2004; Kanai et al., 2008) . In one case, Yadav et al. established Fab-Fab interactions as the primary source of self-association, and showed that multiple binding sites exist on the Fab fragment forming self-association networks that lead to high viscosities (Yadav et al., 2011) . Moreover, they found by swapping charged residues between two antibodies that exposed charged residues in the CDR of one antibody were critical for the self-association and highly viscous behavior of the antibody at high concentrations. Bethea et al. identified specific residues in the H-CDR3 of an antibody that contributed to the poor solubility of this antibody, and proposed a Fab-Fab interaction via H-CDR3 and CH1 as the aggregation mechanism (Bethea et al., 2012) . These types of studies lead to a better understanding of the mechanisms responsible for self-association and will help in designing antibodies that are less aggregation prone (Philo and Arakawa, 2009 ).
We analyzed a panel of anti-CCL17 antibodies from the V H 1-69 family by cross-interaction chromatography and found all to exhibit significant protein-protein interaction. We hypothesized that the hydrophobic H-CDR2 of this germline gene was responsible for such properties and that this could be remedied. We mutated the hydrophobic residues in H-CDR2 along with surface-exposed residues in H-CDR1 to a library of potential variants to improve affinity and to reduce the tendency of self-associating protein-protein interaction. We utilized phage display to select variants with higher affinity to CCL17 and again screened for solubility using cross-interaction chromatography. Through this effort we successfully isolated antibodies with reduced protein-protein interaction and improved affinity. We believe that the use of designed antibody libraries is critical for achieving the goals of affinity maintenance or improvement along with improvement in biophysical properties of an antibody.
Materials and methods

Materials
Anti-CCL17 antibodies, 3641 and 364, were purchased from R&D Systems. Anti-CCL17 antibodies, 5F12, 2F8, 4A3 and 6F11, were generously provided by Shinogi, Inc. Human and cynomolgus CCL17 were expressed and purified at Centocor. CNTO607 was used as a control antibody for poor solubility and high retention in cross-interaction chromatography .
Phage panning
Multiple panning methods were employed. In the first approach, biotinylated CCL17, streptavidin-coated magnetic resin (Dynal M280) and the phage libraries (Shi et al., 2010) were blocked in separate tubes via a 1 h incubation with PBST-M (PBS containing 0.05% Tween-20 and 3% non-fat dry milk). After blocking, the biotinylated CCL17 was mixed with the libraries to a final concentration of 100 nM and was held at room temperature for 1 h. The streptavidin-coated magnetic resin was then added to the phage/CCL17 mixture and allowed to incubate for 1 h to capture the biotinylated CCL17 -phage complexes. The resin was then washed 10 times with PBST (PBS containing 0.05% Tween-20), and added to mid-log phase MC1061F 0 Escherichia coli for phage elution. The infected E. coli was grown overnight at 378C on LB (Carb/Glucose) agar plates (Teknova) . The next morning cultures were scraped from the plates in 2 ml 2xYT (20% glycerol) per plate, 50 ml of bacterial suspension was added to 50 ml 2xYT (Carb) , and the cultures were grown at 378C with shaking for up to 2 h. When the cultures entered mid-log phase (OD 600nm 0.8), VCSM13 helper phage was added and the cultures were incubated without shaking at 378C for 30 min. Kanamycin and isopropyl b-D-1-thiogalactopyranoside (IPTG) were added to each culture to final concentrations of 35 mg/ml and 1 mM, respectively, and the cultures were grown overnight at 308C with shaking. The amplified phage from the bacterial media was precipitated using polyethylene glycol (PEG)/NaCl and re-suspended in 1 ml PBS. Two hundred microliters of the phage was used for the next round of panning. In a second approach, the process above was followed up to phage elution. Instead of overnight growth on a plate, the infected E. coli were grown in 50 ml 2xYT Carb until mid-log phase, at which point roughly 10 11 VCSM13 helper phage were added and the culture held at 378C with no shaking for 30 min. Kanamycin and IPTG were then added to each culture to final concentrations of 35 mg/ml and 1 mM, respectively, and the cultures were grown overnight at 308C with shaking. The amplified phage from the bacterial media was precipitated using PEG/NaCl and re-suspended in PBS. Two hundred microliters of the phage was used for the next round of panning. The third and fourth approaches were similar to the steps outlined above, except that the biotinylated target was captured on the magnetic resin prior to mixing with the libraries.
After three or four rounds of panning, phagemid DNA was isolated from the infected MC1061F 0 cells and digested with restriction enzymes NheI and SpeI to remove the sequence encoding pIX. The restriction digestion was run on a 1% agarose gel and the linearized plasmid DNA was excised and purified using Qiaquick gel extraction columns. This DNA was then self-ligated with T4 DNA ligase, resulting in an in-frame His-tag at the C-terminus of the heavy chain. The ligated DNA was electroporated into MC1061F 0 cells and plated onto LB (Carb/Glucose) agar plates.
Affinity maturation selections were carried out in a similar fashion. The light chain maturation selections were carried out using the first, second and fourth approaches outlined above. The heavy chain CDR 1 and CDR2 maturation selections were carried out using the third approach outlined above. In the maturation selections, biotinylated CCL17 was used at 10 nM in the first and second rounds and 1 nM in the third round.
ELISA screening
Fab expression and antigen binding enzyme-linked immunosorbent assays (ELISAs) were performed. Colonies were picked and grown in 1000 ml 2xYT/Carb at 378C during the day until their OD 600nm was 1.0. IPTG was added to a final concentration of 1 mM and cultures were grown overnight at 308C with shaking. Maxisorp 96-well plates were coated with either 5 mg/ml sheep anti-human-Fd (The Binding Site) or 5 mg/ml of streptavidin. To the streptavidin-coated plates, 2 mg/ml Bt-CCL17 was added to display the antigen for Fab binding. Plates were blocked in PBST-M. Cultures were centrifuged at 3500 rpm for 10 min. Spent culture supernatant containing Fab was added to both the bt-huCCL17 displayed plate and the anti-human-Fd coated plate. Anti-human Kappahorseradish peroxidase (HRP, 1 : 5000 in PBST; Southern Biotech) was added to detect Fabs in both ELISAs. Finally, a chemiluminescent substrate, PoD (Roche), was added and the plates assayed in a Perkin Elmer EnVision plate reader.
Epitope binning
Streptavidin-coated Octet biosensor tips (ForteBio) were used to epitope bin a set of commercial antibodies (2F8, 4A3, 5F12, 6F11, 364, 3641) in a manner similar to that previously described (Abdiche et al., 2009; Tornetta et al., 2012) . First, 10 mg/ml of bt-hCCL17 was loaded onto streptavidin sensor tips for 900 s. Following two 100 s baseline steps the commercial antibodies were individually loaded in an association step for 600 s onto the tips at 10 mg/ml to determine their relative on-rates followed by a dissociation step for 600 s to determine their relative off-rates. From these data, 5F12 and 2F8 were identified as the commercial antibodies with the strongest relative affinities. For epitope binning, a similar Octet method was used, except that after 5F12 or 2F8 had bound to CCL17, the dissociation step was replaced by a 600-s loading step using a second antibody from the remaining panel of lower affinity commercial antibodies. If the second antibody showed mass accumulation to the tips, it was considered to bind to a different epitope than the primary antibody. Through this approach we identified three different competition groups that were represented by mAbs 364, 2F8 and 6F11 in subsequent experiments.
De novo isolated Fabs were binned by epitope-based competition ELISAs where CCL17 was captured by the aforementioned antibodies representing the three epitope groups. Maxisorp (Nunc) plates were coated with a commercial antibody representing each of the epitope groups. Plates were blocked with PBST-M. To the antibody-coated plates, CCL17 was added at 1 mg/ml. Fab-expressing E. coli cultures were centrifuged at 3500 rpm for 10 min and the spent culture supernatant was added to the captured CCL17. Anti-human Kappa-HRP (Southern Biotech) was added to detect Fabs bound to CCL17. Finally, a chemiluminescent substrate (Pierce) was added and the plates were assayed in a Perkin Elmer EnVision plate reader. If Fab was detected, it was considered to be from a different bin than that of the capture antibody on the plate.
For the ranking ELISA each sequence unique Fab was captured on anti-hu(Fd)-coated plates. Bt-CCL17 was added to these plates at a range of concentrations from 1.0 to 0.001 mg/ml. Plates were washed and SA-HRP (Pierce) was added to detect antigen binding using a chemiluminescent substrate as noted above.
Calcium-flux assay
Full-length IgGs were screened for the ability to inhibit CCL17-mediated calcium flux in CCRF-CEM cells (ATCC#: CCL-119) as previously described (Santulli-Marotto et al., 2013) . In brief, cells were cultured in RPMI þ GlutaMAX supplemented with 10% FBS; 10 mM Hepes, 1 mM sodium pyruvate, 4.5 g/l glucose and 1.5 g/ml sodium bicarbonate at 378C with 5% CO 2 . Cells were loaded with Fluo-8 NW dye prior to incubation with human CCL17 in the presence and absence of purified test mAbs. Fluorescence intensity as a result of calcium mobilization was determined by reading plates on an FDSS 6000 Hamamatusu (Bridgewater, NJ) at 490 nm excitation and 525 nm emission.
SEA
Solution equilibrium affinity (SEA) was used to analyze the binding of anti-CCL17 full-length IgGs to human and cynomolgus CCL17. The procedure for these experiments was similar to that used by Haenel et al. (2005) . To prepare the antigen -antibody complexes, human CCL17 or cynomolgus CCL17 ( prepared at Janssen R&D) was serially diluted nine times in Tris-buffered saline containing 0.05% Tween-20, TBST (Thermo Scientific) at a 1 : 6 ratio starting at a concentration of 2 mM in 96-deep well polypropylene plates. Equal volumes of the anti-hCCL17 mAbs at 40 pM or 200 pM were added to each chemokine dilution to obtain mixtures containing the serial dilution of chemokines starting at a final concentration of 1 mM and a constant concentration (20 pM or 100 pM) of anti-CCL17 antibody. The mixtures were prepared in duplicate and incubated at 48C for 48 h to reach equilibrium. The free antibody was detected using a SECTOR Imager 6000 (Meso Scale Discovery) instrument. The resulting binding curves were fitted to obtain the dissociation equilibrium constant (K D ) using the GraphPad Prism software (v 5.01) using a 1 : 1 binding model to perform nonlinear least-square regression analysis of the data.
Cross-interaction chromatography
Polyclonal human IgG was coupled to a Hi-Trap N-hydroxy succinimide ester 1 ml chromatography column (GE Health care) by adding 3 ml of a 10 mg/ml solution of the full-length IgG in coupling buffer (0.1 M NaHCO 3 pH 8.1, 0.5 M NaCl). The detailed chromatographic procedure and the determination of the retention factor k 0 for each sample were carried out according to Jacobs et al. (2010) . All chromatography measurements were performed using an Agilent high-performance liquid chromatography system equipped with an autosampler at 108C.
Affinity maturation libraries
Light chain in-line maturation libraries were described in the de novo pIX library construction (Shi et al., 2010; Tornetta et al., 2012) . The V H regions of the Fabs isolated in the primary panning were cloned into the light chain library phagemids causing a complete re-diversification of the light chain for each Fab. The V H regions were obtained by restriction digestion of DNA minipreps using NcoI and ApaI. The V H regions were gel isolated and ligated into similarly digested light chain library DNA. Ligations were purified and electroporated into MC1061F 0 cells. Cells were grown in 2xYT (Carb) until log phase growth (OD 600nm 0.6) was achieved. VCSM13 helper phage was added and the cultures were incubated at 378C for 30 min. Kanamycin and IPTG were added to each culture to final concentrations of 35 mg/ml and 1 mM, respectively, and were grown overnight at 308C with shaking. The phage from the bacterial media was precipitated using PEG/NaCl and re-suspended in PBS.
Heavy chain maturation libraries
The V H 1-69 H-CDR1/CDR2 library was chemically synthesized as multiple oligonucleotides and then assembled into the full-length fragment as described (Evans, 2003) . Specifically the final assembly was achieved with a combination of three approaches: standard assembly, standard library assembly and a library of dimers (Supplementary Table SI) . The non-library regions were made using single 24-and 48-mer oligonucleotides. CDR1 was assembled as a standard library of 78 (13X6) forward and 78 reverse oligos. CDR2 was assembled as a library of dimer oligos (Supplementary Material). Position 98 in this assembly was varied with four different oligos each containing one of the four amino acids P, A, V, W. The other six positions in CDR2 were modified by making D-dimer mixture libraries (Supplementary Table SI ). The resulting assembly contained four forward and four reverse dimer oligos. Varied molar ratios of D-dimers were used here (0.2 GG/1.0 AT/1.0 CT). This variation of the dimer mixture was expected to reduce the occurrence of tryptophan. The fragment containing CDRs 1 and 2 was PCR-amplified from the NcoI site within the pelB leader sequence through the beginning of V H framework 3. The fragment from V H framework 3 through the heavy chain J-region was PCR-amplified from M71 heavy chain plasmid DNA. The two fragments were then combined using overlap extension PCR to generate a full-length V H library fragment. The heavy chain library fragment was gel isolated, digested with NcoI þ XhoI and ligated into these sites of the phagemid containing the M71 light chain. Ligations were purified and transformed into MC1061F 0 cells. Cells were grown in 2xYT (Carb) until log phase growth (OD 600nm 0.6) was achieved. VCSM13 helper phage was added and the cultures were incubated at 378C for 30 min. Kanamycin and IPTG were added to each culture to final concentrations of 35 mg/ml and 1 mM, respectively, and grown overnight at 308C, shaking. The phage from the bacterial media was precipitated using PEG/NaCl and re-suspended in PBS. Transformation efficiency for the M71 H-CDR1/CDR2 library was 2 Â 10 7 .
Results
Isolation and maturation of antibodies to CCL17 by phage display
Human CCL17 was subjected to biopanning using the de novo pIX Fab libraries (Shi et al., 2010) , consisting of V H 1-69, 3-23 and 5-51 heavy chain libraries paired with V k 1-39, 3-11, 3-20 and 4-1 light chain libraries. Following four rounds of biopanning monoclonal Fabs were screened for binding to CCL17 in an ELISA and positive clones were sequenced. Fabs were converted to IgG and tested for their ability to block signaling through CCR4 in a calcium-flux assay (data not shown).
Antibodies that inhibited CCL17-mediated calcium flux were further characterized by epitope binning. We utilized an Octet biosensor to define the epitopes of six commercially available antibodies (3641, 364, 5F12, 2F8, 4A3 and 6F11) on CCL17. Biotinylated human CCL17 was loaded onto streptavidin sensor tips, followed by 5F12 or 2F8 binding to CCL17. Next, a second antibody from the remaining panel of lower affinity commercial antibodies was added and if the second antibody showed mass accumulation to the tips, it was considered to bind to a different epitope than the primary antibody. This effort identified three epitope groups for these six antibodies (Fig. 1) . Fig. 1 . Commercial antibodies were tested for binding to CCL17 using an Octet sensor. Biotinylated CCL17 was captured on a streptavidin tip. Primary antibody (5F12 or 2F8, shown above) was added to the CCL17-coated tips. Secondary antibody was subsequently added. If the secondary antibody showed mass accumulation to the tips, it was considered to bind to a different epitope than the primary antibody. Six commercial antibodies were examined in this competition assay and placed in three epitope groups.
De novo isolated Fabs were tested for binding to CCL17 captured by antibodies representing these three epitope groups. This resulted in five binding groups, the initial three defined by the commercial antibodies and two additional ones where Fabs bound to CCL17 when paired with more than one of the primary antibodies or with none.
We next conducted binding assays using the Fabs isolated from our phage library to assess binding to CCL17 captured by an antibody (364, 2F8, 6F11) from each of the three epitope groups. The antibodies we identified by phage panning fell into one of five epitope groups: competitive with one of 364, 2F8 or 6F11; competitive with more than one of 364, 2F8 or 6F11; or competitive with none of these antibodies. This information was used to separate clones for affinity maturation as previously described (Tornetta et al., 2012) . Within each epitope group, each heavy chain clone was paired with its matching light chain library as a pool. This approach resulted in the construction of twelve libraries comprising 47 unique heavy chains (Supplementary Materials). These libraries were panned at high stringency and screened for binding relative to the parental clones within each library. Clones with improved relative affinity were selected for sequencing. Three of the libraries yielded no binders and nine of the libraries yielded improved clones from 20 of the original 47 antibodies, covering three of the five epitope groups. Eight of the most improved clones along with their parental Fabs were converted to IgG for further characterization. These antibodies were all derived from the V H 1-69 germline gene, except for those from the M24 parent, which was a V H 5-51 antibody.
Affinity and activity of anti-CCL17 antibodies
The eight affinity matured antibodies along with their parental antibodies were assessed as full length IgGs for affinity to human CCL17 using a solution equilibrium measurement (SEA). In order to measure the affinity of an interaction using SEA, a series of solutions with a fixed concentration of one interactant (A) and varying concentrations of another interactant (B) are prepared and allowed to reach equilibrium. After equilibration, the concentration of free 'A' is determined and the resulting binding isotherms are fitted to a binding model to obtain the affinity. In this assay, the light chain affinity matured antibodies showed improved affinity to CCL17 by 2-100-fold with the best antibodies achieving affinities of 60-111 pM (Table I) . The M24 antibody, derived from the V H 5-51 germline gene, showed weak affinity, greater than 10 nM, and its matured variants only showed modest improvement to 5 and 2 nM. The antibodies were also tested for inhibition of CCL17 signaling in a CCR4 calcium-flux assay. Anti-hCCL17 mAbs were pre-incubated with or without CCL17 and then added to CCRF-CEM cells containing Fluo-8 dye-loading buffer and Ca 2þ flux was measured by fluorescence intensity. All clones inhibited CCL17 signaling at similar levels in this assay (Table I ). The inhibition curve for anti-CCL17 antibodies had a very sharp slope, such that an affinity difference of 100-fold exhibited a less than two-fold difference in signaling inhibition. Inhibition of signaling did not have any correlation with epitope group.
Cross-interaction chromatography analysis of anti-CCL17 antibodies
We next wished to examine these antibodies for protein-protein interaction, an indicator of solubility. We used a simple chromatography assay, cross-interaction chromatography, which measures interaction of an antibody with a polyclonal human IgG column (Jacobs et al., 2010) . Excessive retention on the polyclonal IgG column, indicated by a high k 0 value, often suggests that the antibody is prone to self-association and will likely have poor solubility (Jacobs et al., 2010) . The full length anti-CCL17 IgGs were examined by cross-interaction chromatography for interaction with polyclonal human IgG. A control antibody with solubility greater than 100 mg/ml and an antibody with poor solubility, CNTO607 (Bethea et al., 2012) , were included in the experiment and displayed k 0 values of 0.08 and 1.17 respectively. All of the anti-CCL17 antibodies exhibited varying degrees of interaction with the polyclonal IgG (Table I) , with many showing significant column retention. Additionally, some of the antibodies displayed interaction with the column matrix, which may indicate a propensity to interact with other materials. The M71 antibody displayed the lowest k 0 value at 0.38, indicating that it had the least amount of protein-protein interaction in this panel. This k 0 value, however, is still relatively excessive given that the majority of antibodies we have screened have k 0 values close to zero. Most antibodies with desirable levels of solubility have k 0 values ranging from 0.01 to 0.3.
Engineering reduced protein -protein interaction
Protein-protein interaction can be caused by concentrated hydrophobic residues or by exposed charge residues (Shire et al., 2004; Philo and Arakawa, 2009; Yadav et al., 2011) . The V H 5-51 clone, M24, has a highly charged H-CDR3, 'EWEEDLY', but no hydrophobic patches, suggesting that the exposed charged residues contribute to the high levels of protein-protein interactions seen with this antibody and its matured variants. Since H-CDR3 is so critical for binding, we did not consider mutagenesis of this clone for improved biophysical properties to have a high probability of success. The remaining antibodies in our panel were from the V H 1-69 gene, which has notably hydrophobic CDRs. We hypothesized that mutagenesis of these CDRs could result in molecules with better biophysical properties. As the M71 antibody displayed high affinity and only moderate protein-protein interaction, we selected this clone for optimization. A library was designed for randomizing surface-exposed residues (Almagro, 2004 ) within H-CDR1 and H-CDR2, substituting germline residues with a subset of biochemically diverse amino acids (Table II) . This set of amino acids covers a diverse range of biochemical properties, e.g., acidic (D), basic (R), small (G, A), hydrophobic (W) and polar (S, T, Y, N). A limited panel of amino acids was chosen to allow for randomization of numerous positions, while keeping Affinity matured antibody variants are grouped under each parental antibody, M13, M11, M24 and M44. *Antibodies showed interaction with the column in the absence of IgG.
Isolation and optimization for affinity and biophysical characteristics of anti-CCL17 antibodies from the V H 1-69 germline gene overall combinatorial diversity to an achievable level (1 Â 10 9 ). Hydrophobic residues were included, but limited to one large hydrophobic (W) and the smaller alanine, in case some hydrophobicity was required to maintain binding. Phage panning was performed at high stringency to identify new clones with high affinity to CCL17. This effort produced a panel of unique clones with mutations in H-CDR1 and 2 with higher relative affinity. We were also interested in cross-reactivity to cynomolgus CCL17 for potential non-human primate toxicology studies. The parental mAb, M71, had low affinity to cynomolgus CCL17 (.10 nM, as the binding curve did not reach maximal binding at this concentration, data not shown). The hits isolated from the H-CDR1/2 library ranged from 2 nM to 200 pM affinity to cynomolgus CCL17 (data not shown), suggesting that that while this approach was designed to reduce protein-protein interaction it simultaneously generated new contacts to drive affinity to the cynomolgus protein.
M71 has a potential N-linked glycosylation site within H-CDR3, which could be a liability for activity or heterogeneity of the molecule. In the top eight clones from the H-CDR1/ CDR2 library panning, the asparagine residue in H-CDR3 was mutated to D, S, T or Q. These variants were screened for relative binding activity. We found that mutation of N to Q or S maintained or improved affinity. These variants were then converted to IgG and purified for affinity measurement and protein -protein interaction.
These antibodies demonstrated an improvement in affinity of 10-60-fold and several were found to exhibit reduced protein -protein interactions (Table III) . Interestingly, overall hydrophobicity was not significantly reduced in the clones exhibiting reduced protein -protein interaction. The proline at Position 52 was mutated in most clones, suggesting a structural alteration to the loop, and most clones with such mutations demonstrated reduced protein -protein interactions. All clones showed changes to the F54 residue and clones with reduced protein -protein interactions had small polar residues, S or T, at this position. Additionally, mutation of I51 to a charged or polar residue (D or S) appears in clones with reduced proteinprotein interactions. M159 exhibits a high CIC k 0 value and has the F54S mutation along with the mutation of I51 to the large partially hydrophobic tyrosine and retains the proline at Position 52. M163 retains the proline at Position 52 and has I51A and F54Y mutations and retains a moderately high level of protein -protein interaction, again possibly due to the aliphatic residue at Position 51. M162 has I51D, P52W and F54S mutations and displays diminished protein -protein interaction, further suggesting the negative effects of proline at Position 52 and the positive effects of a charged residue at Position 51. M166 displays low protein -protein interaction and has the F54S mutation along with mutation of I51 to a polar amino acid, threonine, but retains the proline at Position 52. Lastly, the two antibodies with the lowest k 0 values, M164 and M165, have I51D, P52V and F54T mutations. These data suggest that mutation of P52 along with mutation of I51 to polar or charged residues and F54 to small polar residues improves the biophysical characteristics of this particular V H 1-69 antibody.
Discussion
The V H 1-69 germline heavy chain is a valuable member of the human immune repertoire, serving as a key recognition element in early response to various pathogens. It is highly represented in the database of human antibodies and is well represented in selections from antibody libraries derived from the natural human immune system. This gene was incorporated as a scaffold for our synthetic Fab library (Shi et al., 2010) . Panning of this library has produced numerous antibodies to a variety of antigens. In this paper, we report the characterization, affinity maturation and biophysical optimization of several V H 1-69 antibodies directed to the chemokine, CCL17.
CCL17 is a chemokine involved in the inflammatory response in a variety of inflammatory diseases. It acts as a chemoattractant for dendritic cells and Th2 cells, which then secrete inflammatory cytokines (Lieberam and Forster, 1999; Stutte et al., 2010) . To inhibit this activity, we isolated a panel of neutralizing antibodies against CCL17 and binned them by competition group. We pooled heavy chains by epitope bin and generated light chain libraries, matching selected heavy Table II chains with their original light chain. These affinity maturation libraries were panned at high stringency and improved clones were isolated and converted to IgG. When expressed and purified, some of the clones displayed interactions with the size exclusion chromatography column matrix. These antibodies were examined for affinity by solution equilibrium analysis. Clones ranged in affinity from 2 nM to 60 pM. The antibodies were also analyzed for protein -protein interaction as a predictor of solubility. All of these antibodies displayed significant degrees of interaction with human polyclonal IgG, suggesting suboptimal solubility. Almost all of these antibodies were derived from the V H 1-69 germline gene, which has a particularly hydrophobic H-CDR2. This region is often critical for interaction with epitopes on proteins from pathogens such as human immunodeficiency virus (HIV) and influenza. The HIV antibodies, D5 and 412D, and the influenza antibody, CR6261, are derived from the VH1-69 germline gene and share nearly identical H-CDR2 sequences (Da Silva et al., 2010; Lingwood et al., 2012) . V H 1-69 antibodies without mutations in the germline encoded region can engage influenza HA with enough affinity to engage a B-cell response. The phenylalanine residue at Position 54 is required for contact with antigen for all of these antibodies and specifically inserts into a cavity of hemagluttinin to interact with Trp153 (Xu et al., 2013) . Genetic polymorphism at this position to leucine ablates HA binding by the VH1-69 germline antibodies, possibly affecting vaccine immune response (Lingwood et al., 2012) . Recently, Lerner proposed that V H 1-69 could serve as an 'emergency' response element, reacting quickly to pathogens to generate a primary immune response through polyspecificity to hydrophobic pockets in proteins (Lerner, 2011) . The H-CDR3 region from these anti-pathogen protein antibodies has a minimal contribution to binding specificity. Use of a highly diverse H-CDR3 library in combination with the germline V H 1-69 framework could provide additional specificity to such a naturally reactive protein scaffold. In fact, in our work, we routinely find that the V H 1-69 library generates a high hit rate in phage display selections for the diverse panel of more than 50 antigens that we have panned (data not shown) (Shi et al., 2010) .
A challenge for production of recombinant proteins is the potential for aggregation and low solubility. Protein aggregation can be caused by hydrophobic or charged interactions between molecules (Jespers et al., 2004a,b; Conrath et al., 2005; Dudgeon et al., 2009; Yadav et al., 2011; Chaudhri et al., 2013) . The anti-CCL17 antibodies we isolated demonstrated high levels of protein-protein interactions with polyclonal IgG immobilized on a column. As these antibodies were from the V H 1-69 germline gene, we reasoned that mutagenesis of the hydrophobic H-CDR2 could improve self-association properties, resulting in a viable molecule for therapeutic development. As this region may be important for interaction with antigen, we decided to implement a phage library approach to select for high affinity binding sequences. Several positions within H-CDR1 and H-CDR2 were randomized to a subset of biochemically diverse amino acids. Selections from this library generated a panel of novel clones with apparently equal or improved affinity. In all of the matured clones, the F54 position is mutated to smaller and less hydrophobic residues. Analysis by cross-interaction chromatography shows a marked reduction in protein-protein interaction for some of the matured clones.
Those clones that exhibited reduced protein-protein interaction acquired mutation of F54 to smaller polar amino acids, serine or threonine along with mutation of I51 to a charged (D) or polar (T) residue. Clones that retained protein-protein interaction characteristics have more hydrophobic (A, Y) substitutions at Position 51 and charged (D) or large hydrophobic (Y) substitutions at F54. Mutagenesis of F54 alone to D, S or T was sufficient to improve protein-protein interactions, but resulted in a diminished affinity for CCL17. In the combinatorial mutants, the proline at Position 52 appears to contribute to elevated proteinprotein interactions as it is generally mutated in the improved antibodies. Differences in H-CDR1 may also contribute to an improved protein-protein interaction profile. However, it is difficult to correlate the combination of amino acids within H-CDR1 with those in H-CDR2 that may promote better behavior. This complexity suggests that simple mutagenesis of a single 'bad' amino acid may not be sufficient to improve the desired properties of affinity and solubility.
Engineering for both high affinity and positive biophysical characteristics is a challenge in antibody discovery. In our work to identify and affinity mature antibodies to CCL17, we were able to generate a panel of high affinity antibodies that had a propensity to interact with IgG and aggregate. As these antibodies were derived from the V H 1-69 germline gene, one possible cause of this non-specific protein-protein interaction is the hydrophobic H-CDR2, in particular a well-characterized phenylalanine at Position 54. We utilized a phage display approach to mutate and select more favorable H-CDR2 sequences, in order to maintain or improve affinity while reducing nonspecific protein-protein interactions. Our results indicated that mutation of F54 was critical to this end, but not sufficient, and mutations in other positions contributed to the two characteristics of interest, affinity and specificity. We therefore have identified positions of interest within the CDRs that should be probed to guide selection of high affinity antibodies from the V H 1-69 germline gene, while conveying favorable biophysical traits. We also demonstrated that a combinatorial approach is necessary to adequately survey this sequence space for isolation of antibodies that retain the dual properties of affinity and manufacturability.
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